miltefosine has been researched along with Insulin Sensitivity in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Miltefosine caused skeletal muscle insulin resistance in vitro by interfering with the insulin-signalling pathway and inhibiting insulin-stimulated glucose uptake." | 7.73 | The anti-leishmanial drug miltefosine causes insulin resistance in skeletal muscle cells in vitro. ( Dey, CS; Verma, NK, 2006) |
| "Miltefosine caused skeletal muscle insulin resistance in vitro by interfering with the insulin-signalling pathway and inhibiting insulin-stimulated glucose uptake." | 3.73 | The anti-leishmanial drug miltefosine causes insulin resistance in skeletal muscle cells in vitro. ( Dey, CS; Verma, NK, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verma, NK | 1 |
| Dey, CS | 1 |
1 other study available for miltefosine and Insulin Sensitivity
| Article | Year |
|---|---|
The anti-leishmanial drug miltefosine causes insulin resistance in skeletal muscle cells in vitro.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Drug Evaluation, Preclinical; Glucose; Insulin; Insu | 2006 |